UG Healthcare (Catalist:8K7) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

8K7 Panoramica delle azioni

UG Healthcare Corporation Limited, una holding di investimento, produce e vende guanti monouso.

8K7 analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	4/6
Dividendi	0/6

Premi

Analisi del rischio

Gli utili sono diminuiti del 5% all'anno negli ultimi 5 anni

Non ha una capitalizzazione di mercato significativa ( SGD80M )

UG Healthcare Corporation Limited Concorrenti

Medtecs International

Catalist:546

S$73.6m

Riverstone Holdings

SGX:AP4

S$1.3b

Vicplas International

SGX:569

S$47.0m

Singapore Institute of Advanced Medicine Holdings

Catalist:9G2

S$82.8m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per UG Healthcare
Prezzi storici delle azioni
Prezzo attuale dell'azione	S$0.13
Massimo di 52 settimane	S$0.23
Minimo di 52 settimane	S$0.086
Beta	0.85
1Variazione di 1 mese	-2.34%
Variazione a 3 mesi	5.04%
Variazione di 1 anno	31.58%
3Variazione a 3 anni	-63.77%
Variazione a 5 anni	127.28%
Variazione dall'IPO	50.00%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	8K7	SG Medical Equipment	SG Mercato
7D	0%	1.1%	1.4%
1Y	31.6%	39.9%	15.0%

Ritorno vs Industria: 8K7 ha avuto una performance inferiore rispetto al SG Medical Equipment che ha registrato un rendimento 41.8 % nell'ultimo anno.

Rendimento vs Mercato: 8K7 ha superato il mercato SG che ha restituito 5.6 % nell'ultimo anno.

Volatilità dei prezzi

Is 8K7's price volatile compared to industry and market?
8K7 volatility
8K7 Average Weekly Movement	6.6%
Medical Equipment Industry Average Movement	7.3%
Market Average Movement	5.0%
10% most volatile stocks in SG Market	15.8%
10% least volatile stocks in SG Market	2.5%

Prezzo delle azioni stabile: 8K7 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 7% ) di 8K7 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1989	898	Keck Keong Lee	www.ughealthcarecorporation.com

UG Healthcare Corporation Limited, una holding di investimento, produce e vende guanti monouso. L'azienda opera attraverso i segmenti Guanti da esplorazione in lattice, Guanti da esplorazione in nitrile e Altri prodotti accessori. Distribuisce prodotti accessori, tra cui guanti chirurgici, guanti monouso in vinile e per camere bianche, maschere facciali e altri prodotti medici monouso.

UG Healthcare Corporation Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di UG Healthcare con la sua capitalizzazione di mercato?
8K7 statistiche fondamentali
Capitalizzazione di mercato	S$77.98m
Guadagni(TTM)	-S$6.06m
Ricavi(TTM)	S$115.21m

0.7x

Rapporto P/S

-12.9x

Rapporto P/E

8K7 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
8K7 Conto economico (TTM)
Ricavi	S$115.21m
Costo del fatturato	S$89.34m
Profitto lordo	S$25.87m
Altre spese	S$31.92m
Guadagni	-S$6.06m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.0097
Margine lordo	22.45%
Margine di profitto netto	-5.26%
Rapporto debito/patrimonio netto	26.6%

Come si è comportato 8K7 nel lungo periodo?

Vedi performance storica e confronto

8K7 Panoramica delle azioni

Premi

Analisi del rischio

UG Healthcare Corporation Limited Concorrenti

Catalist:546

S$73.6m

SGX:AP4

S$1.3b

SGX:569

S$47.0m

Catalist:9G2

S$82.8m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 29, 2024

Ug Healthcare Corporation Limited Announces Retirement of Mr. Wong See Keong as Executive Director, Effective 29 October 2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

Recent updates

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 29, 2024

Ug Healthcare Corporation Limited Announces Retirement of Mr. Wong See Keong as Executive Director, Effective 29 October 2024

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

New minor risk - Financial data availability

First half 2023 earnings released: S$0.008 loss per share (vs S$0.034 profit in 1H 2022)

UG Healthcare Corporation Limited to Report First Half, 2023 Results on Feb 14, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited Approves Special Cash Dividend for the Financial Year Ended 30 June 2022, Payable on 16 December 2022

UG Healthcare Corporation Limited (Catalist:8K7) entered into a share sale agreement to acquire Indigo Teguh Sdn Bhd from Lee Keck Keong for MYR 100.

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Consensus revenue estimates fall by 12%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited Recommends Tax Exempt Special Dividend for Fiscal Year 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

Price target decreased to S$0.44

Full year 2021 earnings released: EPS S$0.19 (vs S$0.023 in FY 2020)

Price target decreased to S$0.55

Less than half of directors are independent

UG Healthcare Corporation Limited Provides Update on Covid-19 Situation in the Group's Manufacturing Division in Malaysia

Company Secretary Kar Yeoh has left the company

Third quarter 2021 earnings released: EPS S$0.056 (vs S$0.011 in 3Q 2020)

Price target decreased to S$0.99

Second quarter 2021 earnings released

UG Healthcare Corporation Limited to Report First Half, 2021 Results on Feb 04, 2021

New 90-day low: S$0.36

New 90-day low: S$0.23

New 90-day low: S$0.60

New 90-day low: S$0.64

First quarter 2021 earnings released: EPS S$0.039

Analysts update estimates

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS S$0.023

Analysts increase revenue estimates to S$240.3m

UG Healthcare Corporation Limited has completed a Follow-on Equity Offering in the amount of SGD 19.0875 million.

Analysts increase revenue estimates to S$180.9m

Full year earnings released - EPS S$0.068

New 90-day high - S$2.91

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

UG Healthcare Corporation Limited Riepilogo dei fondamenti

0.7x